+41 91 682 20 40 info@elixi-int.com

Warning: getimagesize(/home/elixitom/public_html/wp-content/uploads/2016/01/venclexta-logo-22-HR.jpg): failed to open stream: No such file or directory in /home/clients/5f0b4deb973bf941571734948687755e/web/elixi/wp-content/themes/Total/framework/classes/image-resize.php on line 116
Venclexta 4C

FDA Approval: Venclexta

The U. S. Food and Drug Administration approved venetoclax (VENCLEXTA tablets, marketed by AbbVie, Inc. and Genentech USA, Inc.) for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA-approved test, who have received at least one prior therapy.

Information: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm495351.htm

 

Lascia un commento